An expensive but "game-changing" anti-cholesterol drug could soon be offered to hundreds of thousands of people in England and Wales on the NHS.
NHS England says inclisiran, given as a twice-a-year injection, could save about 30,000 lives within a decade.
It normally costs nearly £2,000 per dose but Novartis, which makes it, has agreed an undisclosed discount.
It can lower bad fat in the blood when other cheaper drugs, like statins, have not done enough, says draft advice.
The health watchdog NICE is recommending it as an option for people who have already had a stroke or heart attack and are not responding to other cholesterol-lowering treatments.
Experts hope it will help to cut their risk of further life-threatening cardiovascular events.
Although there is no long-term proof of this yet from studies, they believe it is worth recommending based on existing evidence.
cont
https://www.bbc.co.uk/news/health-58393866